Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. There's a lot of noise around peptides right now so here's what actually changed. The FDA has begun reviewing several peptides that were previously placed on its do not compound list. By BPC 157 Erectile Dysfunction: Exploring the Peptide's Potential Role FDA Issues Warning: Compounding Certain Bulk Drug Substances May Pose Major Legal and Patient Safety Risks Lengea